Zepbound, a drug approved by the FDA, has been shown to reduce the severity of obstructive sleep apnea in obese adults, ...

Tirzepatide is the active ingredient in Zepbound, the FDA approved prescription medicine for Obstructive Sleep Apnea.

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.

Physical and emotional hyperactive symptoms associated with ADHD can have adverse effects on a person’s life. For instance, ...

With 15.5 million U.S. adults currently diagnosed with ADHD, there is a growing focus on warning signs of the disorder.

About three-quarters of adolescents report common mental disorders (CMDs; depression and anxiety), with a high likelihood of ...

“It’s important to understand OSA symptoms and know that treatments ... continue experiencing a benefit for sleep apnea.” At least 25 million adults in the U.S. have sleep apnea, according ...

Zepbound was found to work on moderate to severe obstructive apnea in adults with obesity ... that the improvement in AHI and sleep apnea symptoms in those with OSA is related to weight reduction ...